CiteAb - Data Accelerating Science Data Accelerating Science
Menu
  • Reagent Search
    • Antibodies
      Recombinant, monoclonal & polyclonal antibodies and primary & secondary antibodies.
    • Biochemicals
      Carbohydrates, peptides, bioactive small molecules, buffers, dyes and lipids.
    • Cell Lines & Models
      Cell lines, tissues, bacteria & viruses, and animal models.
    • Kits & Assays
      ELISAs, multiplex immunoassay kits, detection/staining kits and conjugation/labelling kits.
    • Instruments
      Microscopes, flow cytometers, spectrometers, and other laboratory instruments.
    • Nucleotides
      Plasmids, primers, RNA, siRNA, shRNA, gRNA, viral vectors and particles.
    • Proteins
      Enzymes, growth factors, binding proteins (e.g. streptavidin) and protein mixtures (e.g. bovine serum).
  • Image Search
  • Custom Suppliers
    • Antibody Suppliers
      Polyclonal, monoclonal, recombinant or alternative affinity reagent production.
    • Cell line Suppliers
      Knockout cell lines, knockin cell lines, gene activation & repression and reporter cell lines.
    • Histology Suppliers
      Immunohistochemistry (IHC), in situ hybridisation (ISH), tissue microarray staining (TMA), and more.
    • Peptides Suppliers
      Standard and modified sequences, fluorescent, isotope and radioactive labelled peptides, and more.
    • Sequencing Suppliers
      Whole Genome Sequencing, Antibody Sequencing, Targeted Sequencing, and more.
  • Supplier Partnerships
  • Data Services
    • Reagent Suppliers
      Powerful life science market data, accurate product citations & published images and listing on our popular reagent search engine.
    • Pharma, Biotech & Academic Research Institutions
      Accelerate preclinical research by licensing our comprehensive life science reagent database for totally flexible and private use.
    • Investment, Research & Advisory Companies
      Power unique and quantitative analysis into life science reagent and equipment manufacturer performance to help you make more informed investment decisions.
    • Scientific Publishers
      Partner with CiteAb to maximise exposure, researcher benefit and revenue from your publications.
  • Sign in or Register
Sign in or Register
Comments

(PD1-H5229) Human PD-L1 / B7-H1 Protein, His Tag (MALS verified)

Supplied by ACROBiosystems, cited in 8 publications. Applications used include Biolayer Interferometry, Competition Assay, ELISA, FC/FACS, and 1 other.

Go to:
Supplier info
8 citations

General Information

Supplier
ACROBiosystems
Purified
No
Bioactive
No
Nature
Recombinant
Protein Name
Programmed cell death 1 ligand 1
UniProt ID
Q9NZQ7 - PD1L1_HUMAN
Species
Homo sapiens (Human)
Gene
CD274

Supplier provided information

Applications

None provided

Reactivity

  • Homo sapiens (Human)

Additional product information

Synonyms

PD-L1,CD274,B7-H1,PDCD1L1,PDCD1LG1

Protein Names

Programmed cell death 1 ligand 1, B7 homolog 1, PD1L1_HUMAN

UniProt Code History

Q9NZQ7, B2RBA2, B4DU27, Q14CJ2, Q2V8D5, Q66RK1, Q6WEX4, Q9NUZ5

Gene

CD274, B7H1, PDCD1L1, PDCD1LG1, PDL1, B7-H, PD-L1, hPD-L1, ADMIO5


View additional product information

Comments

for this reagent

Add your comment here...
Enabling you to share comments privately within your lab, helping to avoid duplicated effort.
Get free early access and help us shape this new feature. Join the private beta

0 images
8 citations

found in the literature

Applications
  • Biolayer Interferometry
  • Competition Assay
  • ELISA
  • FC/FACS
  • 1 other
Reactivity
  • None Available
Dilutions
  • None Available

Published images

We have not yet identified suitable images that show this product being used, more are being added all the time.

Loading published images for this product

A binding-to-release strategy for targeted anticancer drug delivery.

View PDF

In Nature on 26 August 2026 by Wen, Z., Xu, M., et al.

ATG-101 Is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1-Directed 4-1BB Activation.

View Preprint View PDF

In Cancer Research on 15 May 2024 by Yuwen, H., Wang, H., et al.

Preclinical development of novel PD-L1 tracers and first-in-human study of [68Ga]Ga-NOTA-RW102 in patients with lung cancers.

View PDF

In Journal for Immunotherapy of Cancer on 5 April 2024 by Zhang, Y., Cao, M., et al.

Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity.

View PDF

In Cancer Immunology, Immunotherapy : CII on 1 February 2021 by Wang, Y., Ni, H., et al.

Applications:

Biolayer Interferometry

Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer.

In Nature Medicine on 1 May 2020 by Lu, Y., Xue, J., et al.

Applications:

FC/FACS

Enhanced Expression of PD-L1 on Microglia After Surgical Brain Injury Exerts Self-Protection from Inflammation and Promotes Neurological Repair.

In Neurochemical Research on 1 November 2019 by Chen, Q., Xu, L., et al.

Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy.

View PDF

In Journal for Immunotherapy of Cancer on 18 December 2018 by Fromm, G., de Silva, S., et al.

Applications:

SPR

A Novel PD-L1-targeting Antagonistic DNA Aptamer With Antitumor Effects.

In Molecular Therapy. Nucleic Acids on 13 December 2016 by Lai, W. Y., Huang, B. T., et al.

Applications:

Competition Assay and ELISA

ACROBiosystems logo
  • order@acrobiosystems.com
  • +1 800-810-0816
  • 1 Innovation Way, Newark, DE 19711, USA

ACROBiosystems

Custom Peptides

If you can't find the peptide you're looking for, why not consider a custom reagent from one of these suppliers.

Custom peptide suppliers

Calculators

A collection of useful calculators with more to come!

Use dilution calculator

Report a Problem

Spotted a mistake? Please let us know so that we can put it right!

Report a problem

Join thousands of people who already enjoy the CiteAb newsletter

Stay up to date with improvements to the CiteAb Explore Platform and data services, news of our partnerships, product launches and the CiteAb Awards, and get our latest market data analysis straight to your inbox.

Sign up
×

We just need a few more details to better tailor our newsletter to you:

CiteAb Explore Platform
  • Image search engine
  • Antibody search engine
  • Biochemical search engine
  • Cell Lines & Models search engine
  • Kits & Assays search engine
  • Instruments search engine
  • Nucleotide search engine
  • Protein search engine
  • Custom suppliers
  • Request a Demo
Research Resources
  • Antibody dilution calculator
  • Molarity calculator
  • Finding the right antibody
  • Citing an antibody
Data Licensing
  • Pharma/Biotech
  • Finance
  • Publishers
  • Integrations
Market Data
  • Antibody market data
  • Biochemical market data
  • Cell Lines & Models market data
  • Instrument market data
  • Kits & Assay market data
  • Protein market data
Supplier Partnerships
  • Citation & Image Provision
  • Listing on CiteAb
  • Market Data
  • Case Studies
CiteAb Information
  • Our story
  • Blog
  • Contact
  • Careers
  • CiteAb publications
  • CiteAb awards
  • Facebook
  • LinkedIn
  • Instagram
The world's largest antibody search engine, with results ranked by citations.

Data Accelerating Science

CiteAb helps researchers find reliable reagents through the Explore Platform, combining powerful reagent and image search tools. We also license our world-class data to pharma & biotech companies, investors and sci-tech companies, and partner with leading life science suppliers.

Publication metadata is provided by PubMed®, a database of the US National Library of Medicine. PubMed® is a registered trademark of US National Library of Medicine.

Company registered in England #08530854. VAT #179706954.
Copyright © CiteAb Ltd 2026. All rights reserved.

  • Privacy policy
  • Cookie policy
  • Terms of use
  • Subscription Terms and Conditions

In partnership with:

  • Storm Consultancy
  • University of Bath
Proud recipient of the Queen's Award for Innovation 2022